Cargando…

Identification of a Novel Wnt Antagonist Based Therapeutic and Diagnostic Target for Alzheimer’s Disease Using a Stem Cell-Derived Model

Currently, all the existing treatments for Alzheimer’s disease (AD) fail to stall progression due to longer duration of time between onset of the symptoms and diagnosis of the disease, raising the necessity of effective diagnostics and novel treatment. Specific molecular regulation of the onset and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patil, Manasi, Gamit, Naisarg, Dharmarajan, Arun, Sethi, Gautam, Warrier, Sudha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952699/ https://www.ncbi.nlm.nih.gov/pubmed/36829686 http://dx.doi.org/10.3390/bioengineering10020192

Ejemplares similares

Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma
por: Bhuvanalakshmi, Gurubharathi, et al.
Publicado: (2018)

An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4
por: Varier, Lavanya, et al.
Publicado: (2023)

An efficient human stem cells derived cardiotoxicity testing platform for testing oncotherapeutic analogues of quercetin and cinnamic acid
por: Mandal, Saurabh, et al.
Publicado: (2022)

Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4
por: Bhuvanalakshmi, G., et al.
Publicado: (2017)

iPSC-Derived Glioblastoma Cells Have Enhanced Stemness Wnt/β-Catenin Activity Which Is Negatively Regulated by Wnt Antagonist sFRP4
por: Yasmin, Ishmat Ara, et al.
Publicado: (2023)

Epigenetic reprogramming converts human Wharton’s jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators
por: Bhuvanalakshmi, G., et al.
Publicado: (2017)

Secreted Frizzled-Related Protein 4 Inhibits Glioma Stem-Like Cells by Reversing Epithelial to Mesenchymal Transition, Inducing Apoptosis and Decreasing Cancer Stem Cell Properties
por: G, Bhuvanalakshmi, et al.
Publicado: (2015)

Wnt Antagonist Secreted Frizzled-Related Protein 4 Upregulates Adipogenic Differentiation in Human Adipose Tissue-Derived Mesenchymal Stem Cells
por: Visweswaran, Malini, et al.
Publicado: (2015)

Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option
por: Sabarimurugan, Shanthi, et al.
Publicado: (2020)

Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
por: Murali, Roopak, et al.
Publicado: (2023)

Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents
por: Sajeev, Anjana, et al.
Publicado: (2023)

Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?
por: Warrier, Sudha, et al.
Publicado: (2022)

Stem Cell-based Therapeutic and Diagnostic Approaches in Alzheimer's Disease
por: Abdi, Sadaf, et al.
Publicado: (2022)

SFRP-4 abrogates Wnt-3a-induced β-catenin and Akt/PKB signalling and reverses a Wnt-3a-imposed inhibition of in vitro mammary differentiation
por: Constantinou, Thecla, et al.
Publicado: (2008)

Secreted Wnt antagonists in scrub typhus
por: Ueland, Thor, et al.
Publicado: (2021)

Aspirin Rescues Wnt-Driven Stem-like Phenotype in Human Intestinal Organoids and Increases the Wnt Antagonist Dickkopf-1
por: Dunbar, Karen, et al.
Publicado: (2020)

Critical appraisal on salivary diagnostic for COVID-19
por: Sarode, Sachin C., et al.
Publicado: (2020)

Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review
por: Sethi, Gautam, et al.
Publicado: (2018)

miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease
por: Elzayat, Emad M., et al.
Publicado: (2023)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari, Sneham, et al.
Publicado: (2019)

Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
por: Nizami, Sohaib, et al.
Publicado: (2019)

Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists
por: Yin, Ping, et al.
Publicado: (2018)

The Role of Wnt Signaling in the Development of Alzheimer's Disease: A Potential Therapeutic Target?
por: Wan, Wenbin, et al.
Publicado: (2014)

Molecular dynamics and structure-based virtual screening and identification of natural compounds as Wnt signaling modulators: possible therapeutics for Alzheimer’s disease
por: Manandhar, Suman, et al.
Publicado: (2022)

Alzheimer's disease: new diagnostic and therapeutic tools
por: Racchi, Marco, et al.
Publicado: (2008)

Multipronged diagnostic and therapeutic strategies for Alzheimer's disease
por: Ramesh, Madhu, et al.
Publicado: (2022)

In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer’s disease
por: Satarker, Sairaj, et al.
Publicado: (2021)

Wnt signaling in triple-negative breast cancer
por: Pohl, SÖ-G, et al.
Publicado: (2017)

MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists
por: Lv, Cong, et al.
Publicado: (2017)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

Nkd1 Functions as a Passive Antagonist of Wnt Signaling
por: Angonin, Diane, et al.
Publicado: (2013)

Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
por: Voorham, Quirinus JM, et al.
Publicado: (2013)

Sonic hedgehog and Wnt: antagonists in morphogenesis but collaborators in axon guidance
por: Avilés, Evelyn C., et al.
Publicado: (2013)

Relationship between epigenetic changes in Wnt antagonists and acute leukemia
por: Zhou, Hua-Rong, et al.
Publicado: (2017)

Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathway
por: Vallée, Alexandre, et al.
Publicado: (2020)

Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease
por: Jia, Lin, et al.
Publicado: (2019)

Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics
por: Warrier, Neerada Meenakshi, et al.
Publicado: (2020)

Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4)
por: Deshmukh, Abhijeet, et al.
Publicado: (2018)

GATA6 Activates Wnt Signaling in Pancreatic Cancer by Negatively Regulating the Wnt Antagonist Dickkopf-1
por: Zhong, Yi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_oijncj7r7pgcpccngd44dg855j